Accrue Software, Inc. (ACRU $2.88) is a provider of eBusiness analytic solutions for optimizing visitor response to Web-based Campaign, Content, Commerce, and Affiliate initiatives. For the 6 months ended 9/30/00, revenues totalled $19.8M, up from $6.7M. Net loss totalled $29.8M, up from $8.2M. Revenues reflect an increase in unit sales volumes. Net loss reflects the inclusion of amortization costs. ACRU
Crescent R.E. Equities (CEI $22.31) is a fully integrated real estate company operating as a REIT. CEI provides management,leasing and development services for its properties. For the nine months ended 9/30/00, revenues fell 6% to $528.2M. Net income before extraordinary item applicable to Common totaled $159.7M vs. a loss of $25.5M. Results reflect reduced rental income due to the sale of properties, offset by higher property sale gains and the absence of charges. CEI
CPQ ($18.32) designs, develops, manufactures and markets hardware, software, solutions and services to individuals, businesses and governments in more than 200 countries. For the 9 months ended 9/30/00, sales increased 10% to $30.84B. Net income totaled $1.26B, up from $237M. Revenues reflect strong unit growth in the Consumer segment. Net income alsoreflects decreased operating expenses due to restructuring actions and the absence of a $868M restructuring charge. CPQ
DELL ($22.13) designs, develops, manufactures, markets and services and supports a range of computer systems, includingdesktop, notebooks, & enterprise systems (includes servers and workstations). DELL also markets software, peripherals, service & support programs. For the 39 weeks ended 10/27/00, revenues rose 26% to $23.21B. Net income rose 47% to $1.80B. Results reflect higher sales of servers and notebooks, along with increased financing and other income. DELL
DSGX ($24) is a leading provider of end-to-end logistics solutions that facilitate B2B e-commerce. Its e-fulfillment software and exchange solutions enable companies to create high-speed, high-performance fulfillment networks-aka DeliveryNets. For the 9 mos. ended 10/00, revenues rose 45% to $45.6M. Net loss increased 69% to $30.8M. Results reflectincreases in software licenses and network revenues, offset by the inclusion of $19M in purchased R&D charges. DSGX
Genesis Microchip (GNSS $11.63) designs, develops and markets integrated circuits that manipulate & process digital video and graphic images. For the 6 months ended 9/30/00, revenues fell 15% to $27.9M. Net income fell 33% to $3.5M. Revenues reflect decreased demand for products in the flat panel LCD computer monitor market & a decrease in units sold in the projections systems market. Earnings reflect an increase in research and development costs. GNSS
Gateway, Inc. (GTW $21.10) develops, markets, manufactures and supports a broad line of desktop and portable PC's and PC- related products used by individuals, businesses, governmentagencies & educational institutions. For the FY ended 12/31/00, sales rose 8% to $9.65B. Net income fell 26% to $316M. Revenues reflect continued strong unit growth in the consumer segment. Earnings were offset by a $187M write-down of investments in technology-based companies. GTW
HIL ($6.38) designs, manufactures, markets and supports high-performance data storage systems for the Open Systems computing environment. For the 9 months ended 9/30/00, net revenues decreased 4% to $90.5M. Net income totaled $140K vs. a loss of $10.5M. Revenues reflect a decrease in sales of legacy products and an overall slowness in sales of other product lines. Net income reflects the absence of a $7.4M merger-related and restructuring charge. HIL
ICOS ($49.81) is discovering and developing new pharmaceuticals by seeking points of intervention in disease processes that may lead to more specific and efficacious drugs. For the 9 months ended 9/30/00, revenuesfell 36% to $31.7M. Net loss rose 36% to $51M. Revenues reflect a reduction in reimbursable clinical trial and development activities. Net loss also reflects increased S/G/A expenses due to certain management transition costs. ICOS
IDPH ($168.62) is primarily engaged in the commercialization &research and development of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases. For the 9 months ended 9/00, revenues increased 21% to $104M. Net income decreased 7% to $33M. Revenues reflect the commercialization of Rituxan through the Company's collaboration with Genentech. Earnings were offset by ZEVALIN-related manufacturing expenses.
Immunex (IMNX $37.31) is a biopharmaceutical firm that develops, markets, and manufactures innovative therapeutic products for the treatment of cancer, infectious diseases, and immunological disorders. For the 9 months ended 9/30/00, revenues increased 61% to $611.2M. Net income totalled $105.2M, up from $28.1M. Revenues reflect increased sales ofENBREL. Earnings also reflect increased interest income due to investment funds from issuance of convertible debt. IMNX
Inhale Therapeutic Systems (INHL $34.88) is creating an inhalation drug delivery system to deliver peptides, proteins and other macromolecule drugs into the deep lung. For the 9 months ended 9/30/00, revenues rose 36% to $38.5M. Net loss totalled $57.8M, up from $18.3M. Revenues benefitted from the expansion of the Co.'s collaborative agreement with Pfizer, Inc. Higher loss reflects the scale-up of technologies and manufacturing capability. INHL
InfoSpace, Inc. (INSP $9.06) is a global provider of cross-platform merchant and consumer infrastructure services on wireless, broadband, and communication platforms. For the 9 months ended 9/30/00, revenues totaled $142.8M, up from $42.2M. Net loss applicable to Common before accounting change fell 3% to $185.2M. Results reflect continued growth in the wireless sector, partially offset by increased amortization and acquisition expenses. INSP
Iomega Corporation (IOM $3.67) designs, manufactures and marketsinnovative storage solutions, based on removable-media technology for personal computer & electronics device users.For the 9 months ended 9/24/00, sales fell 11% to $969M. Net income totalled $147.6M, vs. a loss of $124.8M. Revenuesreflect reduced sales of Zip(R) and Jazz(R) drives. Earningsreflect the absence of a $48.3M restructuring charge, lower manufacturing costs and a higher margin product mix. IOM
InfoUSA (IUSA $2.75) and its subsidiaries, provides business andconsumer marketing information products and data processing services throughout the United States and Canada. For the 9 months ended 9/00, net sales rose 25% to $235.8M. Net loss before extra. item totalled $7M vs. income of $12.9M. Revenues reflect the acquisition of Donnelley. Net loss suffered from higher S/G/A costs, a $4.1M non-cash stock compensation expense, and higher debt levels. IUSA
LTBG ($13.56) develops, markets and supports a network of integrated products/services that enable telecommunications carriers to improve their customer acquisition & retention processes. For the nine months ended 9/30/00, revenues rose 31% to $85.7M. Net income rose 68% to $9.4M. Revenuesreflect a higher volume of qualification and activation transactions. Net income reflects lower selling, general and administrative expenses as a percentage of revenues. LTBG
MYGN ($56.00) is engaged in the discovery and sequencing of genes related to major common diseases. MYGN operates a genetic predisposition testing lab and develops products to prevent or treat the diseases associated with these genes. For the 3 months ended 9/30/00, revenues rose 58% to $10.8M. Net loss fell 6% to $2.1M. Revenues reflect increased research revenue from strategic alliances. Lower loss benefitted from increased interest income. MYGN
TriQuint Semiconductor, Inc. (TQNT $43.22) designs, develops, manufactures & markets high performance analog and mixed signal circuits for the wireless communications, telecommunications and computer markets. For the 9 months ended 9/30/00, revenues rose 84% to $210.5M. Net income totalled $48.3M, up from $14.7M. Revenues reflect increaseddemand across all product lines. Net income reflects improved production yields and increased interest income. TQNT
Washington Mutual (WM $44.06) is a regional financial services company committed to serving consumers & small to mid-sized businesses. For the 9 months ended 9/00, total interest income rose 14% to $10.15B. Net interest income after loan loss prov. fell 6% to $3.08B. Net income rose 3% to $1.4B. Net interest income reflects increased interest earning assets, offset by decreased interest spread and margin. Earnings reflect higher depositor and retail banking fees.
We will add more stocks to this list during the next two weeks.